Breaking
Moon Surgical

Moon Surgical

Surgical AI & Robotics

Moon Surgical's Maestro system provides surgeons with robotic extra hands during soft tissue procedures, enhancing efficiency and autonomy.

About Moon Surgical

Aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics, developing the Maestro robotic system for laparoscopy assistance.

Leadership Team

Key executives and founders sourced from public LinkedIn profiles.

Chris Toth

Chris Toth

Independent Board Member

In my two-decade+ career in healthcare, I've never lost perspective that we work in an industry where success means we've had a meaningful effect on someone's health, and maybe even helped that person live longer. I'm honored to work with my colleagues to continue our fight against kidney disease and to make a positive impact for patients and their families.

Mark Toland

Mark Toland

Board Member

Mark Toland is the CEO of MMI SpA. Before joining MMI, Mark served as the President and CEO of Corindus where he transformed the company into the industry leader in vascular robotics with the only approved system for coronary, peripheral and neurovascular indications. The Siemens Healthineers acquisition of Corindus for $1.1 billion was the fifth largest medical technology acquisition of 2019. Prior to Corindus, Mark served as Senior Vice President of Boston Scientific, where he built the company’s global solutions business and led all aspects of the U.S. commercial team’s cardiovascular businesses, which represented approximately $4 billion in revenue. Mark brings over 25 years of medical device experience to MMI. In addition, he serves on the Board of Directors for Moon Surgical, a surgical robotics company, Cardiologs, a cardiovascular AI company, and Amplitude Vascular Systems, an Intravascular Lithotripsy company. He also serves as a partner and EIR at Biostar Capital, a healthcare focused Venture Capital firm. Mr. Toland holds a Bachelor of Science in Business Administration from the University of Louisville.

Anne Osdoit

Anne Osdoit

Chief Executive Officer

Through excellent communication and relationship with inventors, investors, team members and key medical opinion leaders, in an international and extremely dynamic environment, I strive to accelerate market access for innovative medical devices and create unprecedented value for my organization and the startups or projects I contribute to with constant engagement and reliability.

Pierre Campredon

Pierre Campredon

Co-Founder & Board Observer (formerly CEO)

LJ

Lisa Jacobs

Vice President of Commercial Strategy

With expertise in medical device sales, I’m a high performing executive sales leader known for formulating and executing scalable strategies to accelerate business expansion, revenue generation, and team development in startup, turnaround, and rapid-growth environments across domestic and global markets. When I was promoted to Vice President of U.S. Sales at Accelus, the company had recently experienced a merger. I developed growth strategies, established new territories, and built a sales team from the ground up that aligned innovative robotic navigation platforms and dual expandable implant products to ortho and neuro spine surgeons. I led our team to increase sales revenue from $17M in 2020 to $26M in 2021 and we’re on target to achieve $40M in sales for 2022. As a trusted advisor to C-level executive decision makers, I turn complex business problems into opportunities for improvement that benefit all parties, take a consultative approach to selling, and boast a significant international network of surgeons. I fostered relationships with executive-level decision makers and distributors in the U.S. east coast territory while Director of Sales – East at Joimax. My efforts contributed to growing the territory to ultimately account for over 40% of the company’s entire sales revenue by expanding the organization’s footprint to target underserved areas. I’m a mission-centric professional known for representing brands through public speaking and published articles, developing top talent, demonstrating leadership excellence, and collaborating with cross-functional teams. As helping others achieve their goals is a priority for me, I’ve coached and mentored multiple direct reports to obtain senior level positions. If you’re looking to network with an executive sales leader who ramps up revenue, builds high performing teams, and demonstrates emotional intelligence, I welcome you to connect with me. AREAS OF EXPERTISE: Executive Team Leadership | Sales Operations | Revenue G

Anne Renevot

Anne Renevot

CFO

Financing (private and public - debt and equity) - Public : IPO in Nyse Euronext Paris – Private Placement – Optional Equity Line - Private : Venture Capital Financing /Loan Venture/Capital Development (financing rounds and senior debt) Strategic & operational financial planning and analysis - Planning and performance management in multi-site and multi-activity companies (P&L and cash) - Development programs and productivity tools design and execution Change management in international environments - Internal & External growth: organizational re-engineering - merger and post-acquisition integration - Accounting harmonization: IFRS / U.S. GAAP Financial communication - Investor relations (roadshows, investors’ meetings, news flow design and press release) - Regulated information (registration documents and financial reports, shareholders meetings)

Jeffery Alvarez

Jeffery Alvarez

Board Director

I love to build the impossible. My approach combines deep engineering capability with a design thinking mindset—blending precision, creativity, and curiosity to identify the right clinical problems and turn them into reality. Whether through hands-on prototyping or leading high-performance teams, I’ve consistently delivered solutions that bridge clinical need and technical execution. Over the past two decades, I’ve helped define, develop, and launch over 24 medical devices, including seven surgical robotic systems—five of which have been used in humans and four launched commercially. I’ve led four platforms through first-in-human trials. I was employee #1 at Auris Health, where I helped shape the product architecture and led early development. I’ve also built and scaled programs at Hansen Medical and now Moon Surgical, where we’re redefining the role of robotics in soft tissue surgery. Robotic systems I’ve built include: 1 microsurgical robot for ophthalmology 1 vascular robotic system 2 endolumenal robots for urology 1 robotic bronchoscopy platform 1 soft tissue surgical platform From pre-formation through commercialization and financing, I’ve operated across every phase of company building—always with a focus on creating meaningful clinical value through purposeful engineering. I hold a BS in Mechanical Engineering from Rensselaer and an MBA from the Haas School of Business at UC Berkeley. Along the way, I’ve developed a deep appreciation for the journey—and love to guide, coach, and support other entrepreneurs and operators building ambitious things.

Mission & Approach

Mission

Create the OR of the future, one that is sustainable, efficient, and digitalized

AI Approach

AI-enhanced intraoperative capabilities, computer vision, real-time surgical assistance

Founding Story

Founded as MastOR, rebranded to Moon Surgical. CEO Anne Osdoit has background from Auris (early days). Company driven by desire to advance global healthcare for patients and innovate the art of surgery.

Products & Solutions

ScoPilot

software

Industry's first AI-enhanced intraoperative capability for surgical robotics

ScoPilot is an AI-enhanced intraoperative capability integrated into the Maestro System, powered by NVIDIA Holoscan. It represents the first AI-enhanced surgical assistance feature in the industry to receive FDA clearance. The technology leverages NVIDIA Isaac for Healthcare to accelerate AI capabilities during surgical procedures.

Deploy: embeddedPricing: undisclosed

Maestro Insights

software

Intelligent software unlocking actionable insights from surgical data

Maestro Insights is a software platform that provides intelligent analytics and actionable insights from surgical procedures. The platform is supported by ISO 27001:2022 and SOC 2 certifications for enhanced data security and quality, enabling healthcare providers to access meaningful operational and clinical data.

Deploy: cloud saasPricing: undisclosed

Maestro System

Flagshipdevice

Robotic surgery assistance platform for laparoscopic procedures

The Maestro System is a surgical robotics platform designed to assist surgeons during laparoscopic procedures. It provides total control, digitalized operating room capabilities, and works with preferred instruments as an integrated solution. The system has FDA 510(k) clearance and CE Mark, and has been used in over 200 patient procedures including cholecystectomies and gynecological surgeries.

Deploy: on premisePricing: undisclosed

Customer Success Stories

Lee Health

health system

Launch and implementation of Maestro Platform for surgical procedures

Read case study →

Surgeon's Point Surgery Center

clinic

First global deployment of Maestro System in an ambulatory surgery center (ASC) setting

Read case study →

Multiple U.S. Healthcare Facilities

health system

First clinical cases in the United States using Maestro System

Over 200 patients treated with Maestro System
Read case study →

Franche-Comté Polyclinic

hospital

Demonstration of Maestro System's simplicity and ease-of-use in clinical practice

Read case study →

Arnault Tzanck Institute

hospital

Inaugural robotics surgeries using commercial Maestro System in Nice, France

Read case study →

Hiring Activity

View Open Roles →
growing

Product & Market

Product Stage

launched

Primary Market

providers

Company Details

Founded
2019
Headquarters
Paris, France
Employees
110
Stage
series b
Profile last updated
June 22, 2026

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Social & Media

Follow on

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as employee counts and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.